Publication Highlight: Activation of the IKK2/NF-κB pathway in VSMCs inhibits calcified vascular stiffness in Chronic Kidney Disease
Publication Highlight: Activation of the IKK2/NF-κB pathway in VSMCs inhibits calcified vascular stiffness
TERMIS AM 2023: Tissue Engineering and Regenerative Medicine International Society
TERMIS AM 2023: Tissue Engineering and Regenerative Medicine International Society
Scintica will be exhibiting at the TERMIS AM 2023! We will be exhibiting at the Boston Marriott Copley Place from April 11-14th. Meet us at booth 24!
About the meeting
TERMIS-AM has been scheduled for April 11-14, 2023. The conference venue and location will be Boston Marriott Copley Place, Boston MA. Meet in person, and experience the beauty, culture and fun of Boston in the Springtime. Scintica will be attending in person! Make sure to stop by booth 24 to discuss how we can support you in your tissue engineering and regenerative medicine studies!
Who’s attending?
You will not want to miss this diverse panel of experts as they discuss: “Reflecting on the Past, Living in the Present, and Envisioning the Future of Tissue Engineering for Human Health and Longevity“.
When does the meeting take place?
Tuesday, April 11 – Friday, April 14
Where is this year’s annual conference?
Boston Marriott Copley Place | Boston, MA
Read more about Science!
Application Note: Bioprinting 3D Multi-cellular Cartilage Spheroids Using Laser-Assisted Technology
Application Note: Bioprinting 3D Multi-cellular Cartilage Spheroids Using Laser-Assisted Technology View Paper Here
Publication Highlight: Single High-Dose Erythropoietin Disrupts Bone Homeostasis via Osteoclastogenic Pathways
Publication Highlight: Single High-Dose Erythropoietin Disrupts Bone Homeostasis via Osteoclastogenic Pathways View Paper
Publication Highlight: Long-Term Optical Imaging Reveals Bone Marrow Clearance and Extramedullary Escape in BCMA CAR-NK Therapy
Publication Highlight: Long-Term Optical Imaging Reveals Bone Marrow Clearance and Extramedullary Escape in
Publication Highlight: Overexpression of IL-32γ inhibits skin cancer formation through suppression of NF-κB and its downstream factors
Publication Highlight: Overexpression of IL-32γ inhibits skin cancer formation through suppression of NF-κB
Publication Highlight: The role of phosphodiesterase 5 inhibitors in attenuating obesity-induced metabolic disorders
Publication Highlight: The role of phosphodiesterase 5 inhibitors in attenuating obesity-induced metabolic disorders